Cabergoline: Clinical Trials

1 trial of Cabergoline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow Cabergoline: new trials by email Literature Review of Cabergoline trials Research Report on Cabergoline

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.
cabergoline, controlled-release levodopa / carbidopa - Parkinson Disease
Phase 4TerminatedPfizer2202004-07-012007-05-25

Conditions studied

Parkinson Disease (1)

Sponsors

Pfizer (1)

Countries

Australia (1)  ·  Italy (1)  ·  Spain (1)